Patents by Inventor Xuanling SHI

Xuanling SHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220204591
    Abstract: Provided herein are modified anti-SARS-COV-2 antibodies or antigen binding fragments thereof having extended half life and optimized immune activities. Disclosed herein is also directed to pharmaceutical compositions comprising the same and a method for treating or preventing a disease in human patients that is caused by or related to the infection of SARS-COV-2.
    Type: Application
    Filed: January 5, 2022
    Publication date: June 30, 2022
    Inventors: Zheng ZHANG, Linqi ZHANG, Lei LIU, Qi ZHANG, Bin JU, Xuanling SHI, Qing ZHU
  • Patent number: 11365239
    Abstract: Provided herein are modified anti-SARS-COV-2 antibodies or antigen binding fragments thereof having extended half life and optimized immune activities. Disclosed herein is also directed to pharmaceutical compositions comprising the same and a method for treating or preventing a disease in human patients that is caused by or related to the infection of SARS-COV-2.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: June 21, 2022
    Inventors: Zheng Zhang, Linqi Zhang, Lei Liu, Qi Zhang, Bin Ju, Xuanling Shi, Qing Zhu
  • Publication number: 20210292392
    Abstract: Provided herein are modified anti-SARS-COV-2 antibodies or antigen binding fragments thereof having extended half life and optimized immune activities. Disclosed herein is also directed to pharmaceutical compositions comprising the same and a method for treating or preventing a disease in human patients that is caused by or related to the infection of SARS-COV-2.
    Type: Application
    Filed: November 19, 2020
    Publication date: September 23, 2021
    Inventors: Zheng ZHANG, Linqi ZHANG, Lei LIU, Qi ZHANG, Bin JU, Xuanling SHI, Qing ZHU